References

[1] Ries LAG, Eisner MP, Kosary CL, et al (eds). SEER Cancer Statistics Review, 1975-2002. National Cancer Institute; Bethesda (MD). Available at: http:// seer.cancer.gov/csr/1975_2002/.

[2] Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003;170(1):5-11.

[3] Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, et al. Carcinoma in situ testis, the progenitor of testic-ular germ cell tumours: a clinical review. Ann Oncol 2005;16(6):863-8.

[4] Skakkebsk NE. Possible carcinoma-in-situ of the testis. Lancet 1972;2(7776):2516-7.

[5] Rorth M, Rajpert-De Meyts E, Andersson L, et al. Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl 2000;205:166-86.

[6] Linke J, Loy V, Dieckmann KP. Prevalence of testicular intraepithelial neoplasia in healthy males. J Urol 2005;173(5):1577-9.

[7] Giwercan A, von der Masse H, Skakkebsk NE. Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur Urol 1993;23:104-14.

[8] Almstrup K, Ottesen AM, Sonne SB, et al. Genomic and gene expression signature of the pre-invasive tes-ticular carcinoma in situ. Cell Tissue Res 2005; 322(1):159-65.

[9] Sigg C, Hedinger C. Atypical germ cells of the testis. Comparative ultrastructural and immunohistoche-mical investigations. Virchows Arch A Pathol Anat Histopathol 1984;402(4):439-50.

[10] Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, et al. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with tes-ticular germ cell cancer. J Pathol 2003;200(3):370-4.

[11] Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS 1991;99(7):586-94.

[12] Regadera J, Blanquez MJ, Gonzalez-Peramato P, et al. PCPH expression is an early event in the development of testicular germ cell tumors. Int J Oncol 2006;28(3):595-604.

[13] Skakkebsk NE, Berthelsen JG, Giwercman A, et al. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10(1):19-28.

[14] Rajpert-De Meyts E, Bartkova J, Samson M, et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003;111(1): 267-78.

[15] Almstrup K, Sonne SB, Hoei-Hansen CE, et al. From embryonic stem cells to testicular germ cell cancer—should we be concerned? Int J Androl 2006;29(1):211-8.

[16] de Graaff WE, Oosterhuis JW, de Jong B, et al. Ploidy of testicular carcinoma in situ. Lab Invest 1992;66(2):166-8.

[17] Atkin NB, Baker MC. Specific chromosome change, i(12p), in testicular tumours? Lancet 1982;2(8311): 1349.

[18] Skotheim RI, Lothe RA. The testicular germ cell tumour genome. APMIS 2003;111(1):136-50.

[19] Ottesen AM, Skakkebsk NE, Lundsteen C, et al. High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development. Genes Chromosomes Cancer 2003;38(2): 117-25.

[20] Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of chromosome studies in urological tumors. III. Cytogenetics and genes in testicular tumors. J Urol 1996;155(5):1531-56.

[21] Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002;99(2): 229-37.

[22] Donner J, Kliesch S, Brehm R, et al. From carcinoma in situ to testicular germ cell tumor. APMIS 2004;112(2):79-88.

[23] Holm M, Hoei-Hanson C, Rajpert-De Meyts E, et al. Increased risk of carcinoma in situ in patients with testicular germ cell cancer with ultrasonic microlithiasis in the contralateral testicle. J Urol 2003;170(4 Pt 1):1163-7.

[24] Serter S, Gumus B, Unlu M, et al. Prevalence of tes-ticular microlithiasis in an asymptomatic population. Scand J Urol Nephrol 2006;40(3):212-4.

[25] Miller FN, Rosairo S, Clarke J, et al. Testicular calcification and microlithiasis: association with primary intra-testicular malignancy in 3,477 patients. Eur Radiol 2007;17(2):363-9. May 2006, [E-pub].

[26] Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2-14.

[27] Moller H, Skakkebsk NE. Risk of testicular cancer in sub-fertile men: case-control study. BMJ 1999; 318:559-62.

[28] Heising J, Engelking R. Malignant tumor of the testicle and trauma: correlative evaluation. Urologe A 1978;17(2):73-5.

[29] Prym C, Lauke H. Carcinoma-in-situ of the human testis: tumor cells are distributed focally in the seminiferous tubules. Andrologia 1994;26:231-4.

[30] Heidenreich A, Moul JW. Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? Semin Urol Oncol 2002; 20(4):234-8.

[31] Dieckmann KP, Classen J, Loy V. Diagnosis and management of testicular intraepithelial neoplasia (carcinoma in situ)—surgical aspects. APMIS 2003;111:64-9.

[32] Daugaard G, Giwercman S, Skakkebsk NE. Should the other testis be biopsied? Semin Urol Oncol 1996; 14:8-12.

[33] von der Maase H. Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure? Acta Oncol 2005; 44:523-5.

[34] Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996; 14:3126-32.

[35] Herr HW, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 1997;158:1331-4.

[36] Bruun E, Fromhold-Mollr C, Giwercman A, et al. Testicular biopsy as an outpatient procedure in screening for testicular carcinoma in situ: complications and the patient's acceptance. Int J Androl 1987;10:199-202.

[37] Berthelsen JG, Skakkebsk NE. Gonadal function in men with testis cancer. Fertil Steril 1983;39(1): 68-75.

[38] Manning M, Junnemann KP, Alken P. Decrease in testosterone blood concentrations after testicular sperm extraction for intracytoplasmic sperm injection in azoospermic men. Lancet 1998;352:37.

[39] Hughes PD. Partial orchiectomy for malignancy with consideration of carcinoma in situ. ANZ J Surg 2006;76:92-4.

[40] Heidenreich A, Weissbach L, Holtl W, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166:2161-5.

[41] Giwercman A, van der Maase H, Berthelsen JG, et al. Localized irradiation of the testes with carcinoma in situ: effects on Leydig cell functionand eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991;73:596-601.

[42] PetersenPM,DaugaardG, RorthM,etal. Endocrine function in patients treated for carcinoma in situ in the testis with irradiation. APMIS 2003;111:93-8.

[43] Christensen TB, Daugaard G, Geertsen PF, et al. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998;9(6):657-60.

[44] Coogan CL, Foster RS, Simmons GR, et al. Bilateral testicular tumors: management and outcome in 21 patients. Cancer 1998;83(3):547-52.

[45] Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral tes-ticular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol 2003;169(6):2122-5.

[46] Hentrich M, Weber N, Bergsdorf T, et al. Management and outcome of bilateral testicular germ cell tumors: twenty-five year experience in Munich. Acta Oncol 2005;44(6):529-36.

Urol Clin N Am 34 (2007) 127-136

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment